Major global firms ranging from banks to chipmakers are taking a largely cautious stance on their China business amid a frail recovery at the world's second-largest economy from a pandemic slowdown.
Following are comments from some of the top firms on their China business during the latest reporting season:doubled in China in the first half.third-quarter comparable sales surging 46 per cent.growth driver for the human papillomavirus vaccine.International boosted its earnings.its response to price cuts in China hurt its results there.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: